Literature DB >> 24402111

[Clinical protocol and therapeutic guidelines for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease].

Melani Ribeiro Custódio, Maria Eugênia Fernandes Canziani, Rosa Maria Affonso Moysés, Fellype Carvalho Barreto, Carolina Lara Neves, Rodrigo Bueno de Oliveira, Cristina Karohl, Elisa de Albuquerque Sampaio, José Edevanilson de Barros Gueiros, Vanda Jorgetti, Aluízio Barbosa de Carvalho.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24402111     DOI: 10.5935/0101-2800.20130050

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


× No keyword cloud information.
  4 in total

1.  Effect of parathyroidectomy on bone tissue biomarkers and body composition in patients with chronic kidney disease and secondary hyperparathyroidism.

Authors:  Flavia Ramos de Siqueira; Karin Carneiro de Oliveira; Wagner Vasques Dominguez; César Augusto Madid Truyts; Rosa Maria Affonso Moysés; Luciene Machado Dos Reis; Vanda Jorgetti
Journal:  Eur J Clin Nutr       Date:  2021-01-18       Impact factor: 4.016

2.  The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study.

Authors:  Fabiana Rodrigues Hernandes; Maria Eugênia Fernandes Canziani; Fellype Carvalho Barreto; Rodrigo Oliveira Santos; Valéria de Melo Moreira; Carlos Eduardo Rochitte; Aluizio Barbosa Carvalho
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

3.  The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.

Authors:  Sérgio Gardano Elias Bucharles; Fellype Carvalho Barreto; Miguel Carlos Riella
Journal:  J Bras Nefrol       Date:  2019-07-18

4.  Association between hypocalcemia and rivaroxaban in coagulation disorders: a case report.

Authors:  Alexandre Mio Pos; Mateus Arruda Aleixo; Ana Paula Drummond-Lage
Journal:  Einstein (Sao Paulo)       Date:  2020-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.